secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001193125-22-157444
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 2.03, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MannKind to acquire V-Go device from Zealand Pharma for $10M plus up to $17M in inventory and milestones
--------------------------------------------------------------------------------

- Purchase price: $10.0M plus book value of finished goods inventory (not to exceed $7.0M) and up to $10.0M in sales-based milestone payments.
- Milestone payments triggered when annual V-Go revenue reaches thresholds between $40M and $100M.
- Company will assume a facility lease in Marlborough, MA with monthly payments of $28,895, expiring Feb 2026.
- Up to 40 current and former Zealand employees to be offered positions, including field sales and supply chain roles.
- Closing expected in May 2022 subject to satisfaction of customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000119312522157444/0001193125-22-157444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000119312522157444/d283470d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-157444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer